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Notch signaling plays multiple roles to direct di-
verse decisions regarding cell fate during T cell
development. During helper T (Th) cell differen-
tiation, Notch is involved in generating optimal
Th2 cell responses. Here, we present data in-
vestigating how Notch mediates Th2 cell differ-
entiation. Notch showed a CD4+ T cell intrinsic
role in promoting IL-4 expression that required
GATA-3. In the absence of Notch signals,
Gata3 expression was markedly diminished.
Introduction of an activated allele of Notch1
into CD4+ T cells led to the specific and direct
upregulation of a developmentally regulated
Gata3 transcript that included the exon 1a se-
quences. Furthermore, Notch acted in parallel
with GATA-3 to synergistically activate IL-4
expression. Together, these data implicate
Gata3 as a direct transcriptional Notch target
that acts in concert with Notch signaling to gen-
erate optimal Th2 cell responses.
INTRODUCTION
Notch signaling initiates when a Notch receptor is en-
gaged by a Jagged or Delta-like ligand (Maillard et al.,
2005). This results in two proteolytic cleavages that re-
lease the intracellular domain of Notch (ICN) from the
membrane, allowing it to translocate into the nucleus. In
the nucleus, ICN binds the transcription factor CSL
(gene name Rbpj) enabling Mastermind-like (MAML)
(Nam et al., 2003; Wu et al., 2000) to bind to a groove at
the interface between ICN and CSL (Nam et al., 2006).
MAML in turn recruits critical coactivators, such as p300,
that are required for transcriptional activation (Oswald
et al., 2001; Wallberg et al., 2002; Wu et al., 2000).
During T cell development, Notch signals are critical for
initial T cell specification from multipotent progenitors (Pui
et al., 1999; Radtke et al., 1999; Sambandam et al., 2005)
and development of the ab T cell lineage (Maillard et al.,
2006; Tanigaki et al., 2004; Wolfer et al., 2002). Outside
of the thymus, Notch has roles in shaping peripheral T100 Immunity 27, 100–110, July 2007 ª2007 Elsevier Inc.cell immunity (Adler et al., 2003; Amsen et al., 2004; Mae-
kawa et al., 2003; Minter et al., 2005; Tanaka et al., 2006;
Tu et al., 2005). Recent studies have focused on how
Notch influences helper T (Th) cell differentiation. When
naive CD4+ helper T cells encounter antigen, they differen-
tiate into effector cells that secrete cytokines mediating
immunity toward infectious organisms (Murphy and
Reiner, 2002). Th1 cells secrete IFN-g, express the tran-
scription factor T-bet, and protect against intracellular mi-
crobes (Szabo et al., 2003). Th2 cells produce the cyto-
kines interleukin-4 (IL-4), IL-5, and IL-13, express the
transcription factor GATA-3, and are involved in immunity
against extracellular parasites (Zheng and Flavell, 1997;
Zhu et al., 2004).
Notch has been implicated in almost all aspects of
helper T cell differentiation from negatively or positively
regulating T cell activation to having a role in either Th1
or Th2 differentiation (Adler et al., 2003; Amsen et al.,
2004; Eagar et al., 2004; Maekawa et al., 2003; Minter
et al., 2005; Tanaka et al., 2006; Tu et al., 2005). Gain-
of-function studies suggest that Notch has the capacity
to drive either Th1 or Th2 development (Maekawa et al.,
2003; Minter et al., 2005) or both (Amsen et al., 2004). In
contrast, two different approaches that inhibit Notch
signaling by specifically targeting CSL-dependent sig-
naling via either conditional deletion of Rbpj or expression
of a dominant-negative form of MAML (DNMAML) iden-
tified defects only in IL-4 production (Amsen et al., 2004;
Tu et al., 2005). In addition, DNMAML mice failed to mount
a protective Th2 response against Trichuris muris
(Tu et al., 2005), revealing a physiologic function for Notch
in Th2 differentiation. A recent report suggests that Notch
is involved in promoting very rapid IL-4 production in
cells such as memory-type Th2 cells or NKT cells (Tanaka
et al., 2006). Although no defects were seen in IFN-g pro-
duction in either the conditional Rbpj-deficient or the
DNMAML mice, pharmacological inhibition of the Notch
pathway via g-secretase inhibitors (GSIs) impaired IFN-g
secretion (Minter et al., 2005), suggesting a role for Notch
in Th1 differentiation. Thus, the requirement for Notch
signaling during Th1 or Th2 differentiation may depend
on genetic background, disease model, or mode of Notch
inhibition.
In this report, we focus on the mechanism underlying
Notch-mediated IL-4 production. At the transcriptional
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Notch Directly Regulates Gata3level, Il4 is regulated by signals downstream of the T cell
receptor as well as the transcription factors GATA-3,
STAT6, and NFAT (Ansel et al., 2006). IL-4 transduces
signals through the IL-4 receptor, which leads to phos-
phorylated STAT6 that activates transcription of both
Il4 and Gata3 (Ouyang et al., 2000; Zhu et al., 2001).
This positive reinforcement contributes to the increas-
ingly stable expression of Th2 cytokines. Th2 differen-
tiation is accompanied by progressive changes in
chromatin structure; these changes include histone
modifications and DNA methylation, which regulate ac-
cessibility across the Th2 gene cluster (Agarwal and
Rao, 1998; Avni et al., 2002; Lee et al., 2002). In particu-
lar, DNase I hypersensitivity sites (HSs) have marked
regions that possess regulatory function (Fields et al.,
2004; Takemoto et al., 2000). HS V and HS VA of Il4
were deleted in tandem and resulted in impaired IL-4
expression in both CD4+ T cells and mast cells. This
enhancer region contains a conserved CSL-binding site
that is within HS V and that is responsive to Notch
signals (Amsen et al., 2004; Tanaka et al., 2006). There-
fore, Notch may induce IL-4 expression at least in part
through this region.
GATA-3 exerts its effects as a key regulator of Th2 dif-
ferentiation in several ways. GATA-3 is involved in acute
transcription of Il5 and Il13 and binds to these promoters
(Kishikawa et al., 2001; Zhang et al., 1998; Zhu et al.,
2004). GATA-3 is also sufficient to induce changes in chro-
matin structure at the Il4 locus, and these mondifications
contribute to Th2 differentiation. (Lee et al., 2001; Lee
et al., 2000; Yamashita et al., 2004). Known signals that
activate Gata3 transcription during Th2 differentiation
are IL-4, STAT6, and GATA-3 itself (Kurata et al., 1999;
Ouyang et al., 2000; Zhu et al., 2001). Gata3 is expressed
at various stages of T cell development, starting with the
earliest steps of T cell commitment (Hoflinger et al.,
2004; Sambandam et al., 2005). Similar to other GATA
family members (Minegishi et al., 1998), Gata3 utilizes al-
ternative promoters in different tissues (Asnagli et al.,
2002). In developing Th2 cells, Gata3 transcripts include
the proximal exon 1a, whereas in thymocytes, distal
exon 1b predominates. However, the mechanism by
which these alternative exons are regulated has not
been previously addressed.
Here, we present data demonstrating that in addition
to a defect in IL-4 expression, Gata3 expression was
also impaired in the absence of Notch signals. Notch as-
sociated with Gata3 regions that contained CSL-binding
sites, and this was accompanied by changes in histone
acetylation. In addition, Notch preferentially induced
expression of the developmentally regulated Gata3
transcript that included exon 1a sequences. Furthermore,
GATA-3 activity was required for Notch induction of IL-4.
The dependence of Notch on GATA-3 was consistent
with a synergistic effect observed between Notch and
GATA-3 in promoting IL-4 expression. Together, these
data implicate Gata3 as a direct downstream Notch target
that cooperates with Notch signaling to generate an
optimal Th2 response.RESULTS
Notch Has a Cell-Intrinsic Role in Regulating
IL-4 in Peripheral CD4+ T Cells
We previously found that breeding ROSA26-DNMAML
(dominant-negative MAML) mice with CD4-cre mice re-
sulted in normal lymphocyte development (Tu et al.,
2005). However, IL-4 production by peripheral CD4+ T
cells was defective. Although T cell development ap-
peared normal in these mice, we wanted to confirm that
the resulting IL-4 defect was not due to a defect acquired
when the DNMAML transgene was turned on at the dou-
ble-positive stage in the thymus. To address this, we
took an approach to specifically activate DNMAML ex-
pression in peripheral naive CD4+ T cells. DNMAML
mice were bred with DO11.10 mice that have TCRa and
b transgenes specific for ovalbumin (OVA). CD4+ T cells
from these mice do not express GFP because there was
no Cre recombinase to turn on the DNMAML-GFP protein
(Figure 1A). CD4+ T cells were sorted and treated with
TAT-cre peptide, which is cell permeable (Peitz et al.,
2002). The cells were then stimulated with irradiated anti-
gen presenting cells (APCs) and OVA peptide. After
7 days, cultures contained a mixture of GFP and GFP+
(expressing DNMAML) CD4+ T cells that were then sorted
and restimulated. There was no difference in IFN-g
production between GFP and GFP+ cells (Figure 1B).
However, GFP+ cells produced markedly less IL-4, in con-
cordance with previous results when DNMAML was ex-
pressed in the thymus (Tu et al., 2005). In the reciprocal
experiment, retroviral expression of an activated allele of
Notch1 (ICN1) potently induced (>50-fold) IL-4 when intro-
duced into CD4+ T cells (Figure 1C), whereas its effect on
IFN-g production was modest (1.5-fold increase). Acti-
vated alleles of other Notch family members induced
smaller amounts of IL-4 compared to the effect of ICN1
(Figure 1D). Thus, Notch has a CD4+ T cell-intrinsic role
in inducing IL-4 expression, and Notch1 is the strongest
inducer of IL-4.
Notch Regulates Gata3
Because GATA-3 is a major factor involved in Th2 differen-
tiation and there had been suggestions that Gata3 was
a Notch target in CD4+ T cells (Amsen et al., 2004),
Gata3 expression was examined in the absence of Notch
signals (Figure 2A). After 7 days of culture, Gata3 expres-
sion was markedly reduced in DNMAML CD4+ T cells
compared to the wild-type (WT) controls. Culturing cells
in Th2 conditions (IL-4 and a-IL-12) restored Gata3 ex-
pression to that of wild-type (Figure 2A), probably because
of the combined effects of inducing Gata3 expression via
IL-4 and blocking IL-12 suppression of Gata3. In addition,
ICN1 upregulated Gata3 expression compared to the vec-
tor control (Figure 2B). To determine whether restoring
GATA-3 expression would restore IL-4 production in the
absence of Notch signals, we transduced wild-type or
DNMAML CD4+ T cells with either a control virus express-
ing nerve growth factor receptor (NGFR) or GATA-3-NGFR
(Figure 2C). With the control NGFR virus, DNMAML CD4+Immunity 27, 100–110, July 2007 ª2007 Elsevier Inc. 101
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the control. Expression of GATA-3 induced abundant
amounts of IL-4 in both wild-type and DNMAML CD4+ T
cells. Therefore, expression of GATA-3 rescued IL-4
expression in the absence of Notch signaling.
Notch Associates with Gata3 Regions that Contain
CSL-Binding Sites
To further investigate the possibility that Notch may regu-
late Gata3, we searched for putative CSL-binding sites
within the Gata3 gene locus. We identified multiple CSL
sites and focused our attention on sites that were con-
served between mouse and human Gata3. Conserved
CSL-binding sites were found in regions of high DNA ho-
mology 3, 5, and 10 kb upstream of the translational
start site (Figure 3A). Primers flanking these regions were
Figure 1. Notch Regulates IL-4 in CD4+ T Cells
(A) Tat-cre induces expression of DNMAML. DO11.10 DNMAMLf/+
CD4+ T cells were treated with Tat-Cre to induce expression of
DNMAML. After 24 h, cells were stimulated with irradiated APCs and
OVA peptide in the presence of IL-2. GFP and GFP+ CD4+ T cells
were sorted on day 7. Flow-cytometry plots display GFP expression
prior to Tat-cre treatment and 7 days after culture.
(B) DNMAML expression in peripheral CD4+ T cells results in impaired
IL-4 expression. Equal numbers of GFP and GFP+ CD4+ cells from (A)
were restimulated with plate-bound a-CD3, and supernatants were
collected after 48 hr to determine quantities of IL-4 or IFN-g by ELISA.
Graphs represent the mean of values of triplicate wells ±SD. Data are
representative of three independent experiments.
(C) Notch1 induces IL-4 expression. Wild-type Balb/C CD4+ T cells
were retrovirally transduced with either the control MigR1 or ICN1 (ac-
tivated Notch1). GFP and GFP+ CD4+ T cells were sorted after 6 days.
Equal numbers of GFP and GFP+ cells were restimulated with plate-
bound a-CD3, and supernatants were collected after 48 hr for ELISA.
Graphs represent the mean of values of triplicate wells ±SD. Data are
representative of six independent experiments.
(D) Weak induction of IL-4 by other Notch family members. Wild-type
Balb/C CD4+ T cells were retrovirally transduced with either the control
MigR1 or various activated Notch alleles. Cells were restimulated with
PMA and Ionomycin on day 6. Flow-cytometry plots represent GFP+
cells. Numbers indicate the percentage of CD4+IL-4+ cells within the
gates. Data are representative of three independent experiments.102 Immunity 27, 100–110, July 2007 ª2007 Elsevier Inc.designed to perform chromatin immunoprecipitation
(ChIP). The 10 kb site was 200 bp upstream of the al-
ternative exon 1a and was denoted the ‘‘1a site.’’ The
3 kb site was 2.5 kb upstream of exon 1b and was re-
ferred to as the ‘‘1b site.’’ We compared naive CD4+ T
cells, which do not contain activated Notch, to cells that
were stimulated for 40 hr, a time point shown to have ac-
tivated Notch protein (Adler et al., 2003; Amsen et al.,
2004; Palaga et al., 2003). Naive cells served as a negative
control, and PCR of a-Notch1 ChIP samples did not am-
plify DNA sequences corresponding to the CSL-binding
sites of Gata3 (Figure 3B). Forty hours after stimulation,
Notch1 associated with the 10 kb exon 1a CSL-binding
site of Gata3. Very low binding of Notch1 occurred at the
Figure 2. Notch Signaling Regulates Gata3 Expression
(A) Diminished Gata3 expression in the absence of Notch. Wild-type or
DNMAML CD4+ T cells that were naive and cultured in neutral or Th2
conditions for 7 days were purified. Abundance of Gata3 mRNA was
determined by quantitative RT-PCR. Gata3 expression relative to
Hprt is shown as a mean of values from duplicate wells ±SD. Data
are representative of three independent experiments.
(B) Notch1 induces Gata3 expression. Wild-type Balb/C CD4+ T cells
were retrovirally transduced with either the control MigR1 or ICN1.
CD4+GFP+ T cells were sorted by flow cytometry. Gata3 expression
relative to Hprt is shown as a mean of values from duplicate wells
±SD. Data are representative of three independent experiments.
(C) GATA-3 rescues the IL-4 defect in DNMAML CD4+ T cells. Wild-
type or DNMAML CD4+ T cells were retrovirally transduced with either
the control NGFR or GATA-3-NGFR. Cells were restimulated with PMA
and Ionomycin on day 6. Plots show NGFR+ cells. Numbers indicate
the percentage of CD4+IL-4+ cells within the gates. Data are represen-
tative of three independent experiments.
Immunity
Notch Directly Regulates Gata3Figure 3. Notch Binds to Regions of Gata3 Containing CSL-Binding Sites
(A) Schematic of the 50 region of the Gata3 locus. Gata3 transcription can initiate from either exon 1a or exon 1b. The translational start site begins
within exon 2. Locations of nucleotides matching the CSL-binding sites are shown in bolded sequences. GATA sites are underlined. Arrows imme-
diately flanking these sites are primers used to amplify ChIP DNA. Arrows drawn above exon 1a or exon 1b were used as forward primers coupled with
a reverse primer that annealed to exon 2 to amplify mRNA transcripts. The bottom strand in each box is indicated 50 to 30.
(B) Notch1 binds to the exon 1a CSL-binding site. Naive or CD4+ T cells stimulated for 40 hr were purified and fixed for ChIP. Antibodies used for IP are
a control IgG, a-Notch1, a-CSL, a-acetylated H4 (AcH4), and a-H3. Total histone H3 was used for normalization. Graphs represent quantitative PCR
presented as a mean of the ratios of the amount of IP DNA in each sample relative to total H3 from values of duplicate wells ±SD. Data are represen-
tative of at least three independent experiments.
(C) Notch1 binds weakly to the exon 1b CSL-binding site. The description is the same as (B), except the primers amplified the CSL-binding site
upstream of exon 1b.
(D) ChIP from CD4+ T cells stimulated for 40 hr and quantitative PCR for an irrelevant gene control (Oct4). Data are representative of at least three
independent experiments.
(E) GSI treatment blocks association of Notch1 with Gata3 CSL-binding sites. CD4+ T cells were treated with either DMSO (vehicle control) or GSI and
stimulated for 40 hr, and ChIP was performed. Data are representative of three independent experiments.
(F) CSL binds to putative target sequences within the Gata3 locus. Wild-type or mutant oligonucleotides corresponding to exon 1a or exon 1b CSL-
binding sites were labeled with 32P and mixed with buffer alone or buffer containing purified CSL or Notch1 polypeptides, or both, and electrophor-
esed. Gels were dried, and probes were detected by autoradiography. The control probe contained a consensus CSL-binding site.Immunity 27, 100–110, July 2007 ª2007 Elsevier Inc. 103
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Notch Directly Regulates Gata33 kb exon 1b site of Gata3 (Figure 3C) that was similar to
binding of an irrelevant control (Figure 3D). However, we
consistently observed association at the 1b site, which
could be inhibited by addition of GSI, suggesting that
this was a specific interaction (Figure 3E). Like Notch1,
CSL preferentially bound the exon 1a site in activated
CD4+ T cells. In addition, histone 4 (H4) became hyperace-
tylated at both the 1a and 1b sites after stimulation, indi-
cating that these are regions of open chromatin and are
possible regulatory regions of Gata3 (Figures 3B and
3C). Notch binding did not occur at the 5 kb site (data
not shown). An electrophoretic mobility shift assay
(EMSA) was performed with probes corresponding to
the 1a or 1b sites and CSL or CSL-ICN1 complexes
(Figure 3F). No intrinsic difference was observed between
the 1a or 1b probes. Binding was abrogated with mutated
probes, indicating that the association was specific for the
CSL-binding site. The lack of difference in binding with
bare DNA templates suggests that differences in chroma-
tin structure or presence of other factors might influence
association of endogenous Notch with putative target
sites. Thus, Notch has the potential to regulate Gata3
through either of these sites.
Notch Regulates Exon 1a of Gata3
A previous report demonstrated that Gata3 transcripts in-
cluding exon 1a were preferentially expressed in develop-
ing Th2 cells (Asnagli et al., 2002). We designed primers to
distinguish between the 1a and 1b transcripts (Figure 3A).
DNMAML CD4+ T cells that were stimulated with a-CD3
and a-CD28 and cultured for 7 days in the presence of
IL-2 displayed a relative decrease in both transcripts com-
pared to the wild-type control (Figure 4A). Enforced ex-
pression of ICN1 in CD4+ T cells induced exon 1a tran-
scripts but had no effect on exon 1b expression (Figures
4B and 4C). Exon 1a transcripts were augmented as early
as 36 hr after transduction, reducing the likelihood that the
change was due to indirect effects, and persisted at day 7
after transduction, whereas there was still no alteration in
exon 1b expression at this time point (Figure 4B). These
data reveal that Notch regulatesGata3 expression by aug-
menting amounts of the alternative exon 1a transcript in
CD4+ T cells.
Induction of IL-4 by Notch Requires GATA-3
GATA-3 is essential for expression of Th2 cytokines (Pai
et al., 2003; Zhu et al., 2004). A previous report showed
that the distal 30 enhancer of Il4 was directly responsive
to Notch signals (Amsen et al., 2004). Therefore, we
sought to determine whether Notch could induce IL-4 in-
dependently of GATA-3. To block GATA-3 activity, we
used a dominant-negative GATA-3 allele (DN G3) in which
the DNA-binding domain of GATA-3 is fused to the Dro-
sophila Engrailed repression domain. This construct was
shown to inhibit IL-4 production in developing Th2 cells
(Martins et al., 2005). CD4+ T cells were cotransduced
with a retrovirus expressing DN G3 (GFP) and ICN1
(NGFR) and cultured in Th2 conditions to achieve high
IL-4 expression. Even in Th2 conditions, ICN1 enhanced104 Immunity 27, 100–110, July 2007 ª2007 Elsevier Inc.the abundant amounts of IL-4 production in CD4+ T cells.
Expression of DN G3 significantly decreased both the
percentage of IL-4+ cells (Figures 5A and 5B) and the
amount of IL-4 produced per cell in comparison to con-
trols (Figures 5A and 5B). Furthermore, ICN1 failed to
augment IL-4 production in the presence of DN G3. There-
fore, the ability of Notch to induce IL-4 depends on GATA-
3 activity.
Notch and GATA-3 Synergize to Promote IL-4
Expression
The preceding results demonstrated that Notch-mediated
IL-4 expression is dependent on GATA-3. These data also
Figure 4. Notch Preferentially Induces Expression of Gata3
Transcripts Including exon 1a
(A) Expression of exon 1a and 1b transcripts is diminished in the
absence of Notch signals. Wild-type or DNMAML CD4+ T cells that
were naive or cultured in neutral conditions for 7 days were purified.
mRNA expression of exon 1a or exon 1b of Gata3 were determined
by quantitative RT-PCR. Primers used are illustrated in Figure 3A.
Amounts of transcript compared to Hprt are shown as means of values
from duplicate wells ±SD. Data are representative of three indepen-
dent experiments.
(B) Rapid induction of exon 1a expression by Notch1. Wild-type Balb/C
CD4+ T cells were retrovirally transduced with either the control MigR1
or ICN1. CD4+GFP+ T cells were sorted 36 hr after transduction. Rela-
tive abundance of exon 1a or exon 1b transcripts compared to Hprt is
shown as a mean of values from duplicate wells ±SD. Data represent
two independent experiments.
(C) Notch1 has no effect on exon 1b expression. The description is the
same as (B), except cells were sorted 7 days after transduction. Data
represent three independent experiments.
Immunity 27, 100–110, July 2007 ª2007 Elsevier Inc. 105
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Notch Directly Regulates Gata3show that one mechanism by which Notch influences IL-4
expression is via direct transcriptional control of Gata3. In
addition, the existence of both GATA-3- (Agarwal et al.,
2000; Avni et al., 2002) and CSL- (Amsen et al., 2004) bind-
ing sites in the Il4 locus suggests that Notch and GATA-3
may coordinately regulate the Il4 locus. To address this
issue, we transduced CD4+ T cells with retroviruses
expressing ICN1 and GATA-3 and cultured the cells in
Th1 conditions, which include factors (recombinant IL-12
and a-IL-4) that strongly suppress both Gata3 expression
and Th2 differentiation. Nevertheless, ICN1, by itself, in-
duced IL-4 expression to a similar extent as GATA-3 alone
(Figure 6A). Strikingly, coexpression of ICN1 and GATA-3
resulted in an even more potent effect on IL-4 expression
than either alone. This synergistic effect of Notch and
GATA-3 suggests that these two factors collaborate to
induce IL-4 expression. Moreover, this effect was indepen-
dent of STAT6 and any further positive feedback from IL-4,
thereby demonstrating the robust effect that Notch and
GATA-3 have together (Figure 6A).
GATA-3 autoregulates its own expression in CD4+ T
cells (Ouyang et al., 2000). This occurs in the absence of
STAT6 and therefore independently of IL-4 signaling. In
addition, retrovirally expressed GATA-3 induces expres-
sion of endogenous Gata3 even in the presence of IL-12,
a potent Gata3 repressor. Therefore, we investigated
Figure 5. IL-4 Induction by Notch Is Dependent on GATA-3
Activity
(A) DN G3 antagonizes Notch1 induced IL-4 expression. Wild-type
CD4+ T cells were cotransduced with ICN1 (NGFR), DN G3 (GFP), or
control retroviruses and cultured under Th2 conditions. Cells were
restimulated with PMA and Ionomycin on day 6 and stained for intra-
cellular IL-4. Flow-cytometry plots show GFP+NGFR+ cells. Numbers
represent the percentage of IL-4+ cells within the gates.
(B) Summary of independent experiments. Individual points on graphs
represent results from separate experiments. The mean of the points
within each group is shown as a horizontal line. The left plot displays
the percentage of IL-4 cells as shown in (A). The right graph shows
the mean fluorescence intensity of IL-4 as an indication of the amount
of IL-4 expressed per cell.whether Notch could regulate expression of exon 1a-
derived transcripts in a similar fashion. Stat6/ CD4+
T cells were used to distinguish direct effects from effects
mediated through IL-4, a known mechanism of Gata3
induction, and cultured in Th1 conditions to suppress
endogenous Gata3 expression. Seven days after retroviral
transduction by ICN1 (NGFR), GATA-3 (GFP), or both,
GFP+NGFR+ cells were sorted for analysis of the abun-
dance of Gata3 mRNA. ICN1 or GATA-3 preferentially
upregulated exon 1a-derived transcripts and when ex-
pressed together had an additive effect on exon 1a
expression (Figure 6B). Neither ICN1 nor GATA-3 had an
effect on the exon 1b transcript when expressed alone.
However, there was a modest effect when ICN1 and
GATA-3 were expressed together (Figure 6B). These data
reveal that the effect of Notch in promoting Gata3 expres-
sion is sufficiently potent to oppose IL-12-mediated
repression ofGata3 and occurs independently of signaling
through IL-4. Furthermore, these findings suggest that
Notch and GATA-3 coordinately regulate preferential in-
duction of Gata3 exon 1a expression.
The 30 Il4 enhancer contains a CSL-binding site within
HS V (Figure 6C). This site mediates responsiveness of
the Il4 locus to Notch1 (Amsen et al., 2004). Consistent
with these findings, a-Notch1 ChIP demonstrated that
Notch1 binds directly to HS V (Figure 6D). In addition, con-
served GATA-binding sites were found within HS V
(Figure 6C), and ChIP showed GATA-3 binding in this
region (Figure 6E). The synergistic effect of Notch1 and
GATA-3 may involve cooperation at these sites within
HS V.
An additive effect was also seen with combined expres-
sion of Notch1 and GATA-3 at the Gata3 locus. A con-
served GATA-binding site is located immediately adjacent
to the exon 1a CSL-binding site and GATA-3 bound to this
region (Figures 3A and 6F). GATA-3 also associated with
the region surrounding the exon 1b CSL site (Figure 6F).
Conserved GATA-binding sites are located within the re-
gion amplified by the exon 1b primers (Figure 3A). How-
ever, their locations are not immediately adjacent to the
CSL site. These data suggest that there may also be direct
cooperation of Notch1 and GATA-3 at the Gata3 locus.
DISCUSSION
Recent data identified important roles for Notch in gener-
ating Th2 immunity (Amsen et al., 2004; Tu et al., 2005). In-
hibiting Notch signaling by either expression of DNMAML
or deletion ofRbpj at the double positive (DP) stage did not
perturb T cell development but impaired IL-4 production in
peripheral CD4+ T cells. We now demonstrate that block-
ing Notch signaling specifically in peripheral naive CD4+ T
cells also results in loss of IL-4 production. Furthermore,
introduction of an activated allele of Notch1 into naive
CD4+ T cells results in robust IL-4 induction. Together,
these data demonstrate that Notch regulates IL-4 produc-
tion in a peripheral CD4+ T cell-intrinsic manner. Of the
four mammalian Notch receptors, retroviral expression
of the intracellular domain of Notch1 in CD4+ T cells
Immunity
Notch Directly Regulates Gata3Figure 6. Notch and GATA-3 Synergize to Induce IL-4 Expression Independently of STAT6
(A) Notch1 and GATA-3 synergize to induce IL-4 expression. Wild-type orStat6/ CD4+ T cells were cotransduced with ICN1 (NGFR), GATA-3 (GFP),
or control retroviruses and cultured under Th1 conditions. Cells were restimulated with PMA and Ionomycin on day 6 and stained for intracellular IL-4.
Flow-cytometry plots show GFP+NGFR+ cells. Numbers represent the percentage of IL-4+ cells within the gates. Data are representative of three
independent experiments.
(B) Notch1 relieves suppression of Gata3 expression independently of STAT6. Stat6/ CD4+ T cells were cotransduced with ICN1 (NGFR), GATA-3
(GFP), or control retroviruses and cultured under Th1 conditions. GFP+NGFR+CD4+ T cells were sorted 6 days after transduction. Relative abundance
of exon 1a or exon 1b transcripts compared to Hprt is shown as a mean of values from duplicate wells ±SD. Data represent three independent
experiments.
(C) Schematic of the Il4 locus. HS sites are indicated by arrows below the locus. A conserved CSL site (nucleotides matching the consensus
CSL-binding sites are shown in bold) is located within HS V. Conserved GATA sites are underlined. Arrows flanking HS V were used to amplify
ChIP sequences. The bottom strand in each box is indicated 50 to 30.
(D) Notch1 binds to the CSL-binding site in HS V of Il4. Naive or CD4+ T cells stimulated for 40 hr were purified and fixed for ChIP. Antibodies used for
IP are a control IgG, a-Notch1, a-CSL, a-acetylated H4 (AcH4), and a-H3. Graphs represent quantitative PCR presented as a mean of the ratios of the
amount of IP DNA in each sample relative to total H3 from values of duplicate wells ±SD. Data are representative of at least three independent
experiments.
(E) GATA-3 associates with HS V of Il4. CD4+ T cells stimulated for 40 hr were purified and fixed for ChIP. Antibodies used for IP are a control IgG,
a-GATA-3, and a-H3. Data are representative of at least three independent experiments.
(F) GATA-3 associate with regions upstream of exon 1a and 1b ofGata3. The description is same as that of (E).Oct4was used as a negative control for
GATA-3 binding.strongly induces IL-4 production. However, the intracellu-
lar domains of Notch2–Notch4 weakly induce IL-4 expres-
sion. Because IL-4 production was not impaired in the
absence of Notch1 (Tacchini-Cottier et al., 2004), signal-
ing by one or more of the other Notch receptors may
rescue Notch1 deficiency.
Previous reports suggested a relationship between
Notch and GATA-3 and that GATA-3 may be downstream
of Notch (Amsen et al., 2004; Hoflinger et al., 2004;
Sambandam et al., 2005). We have now utilized a loss-
of-function approach with DNMAML to show that the ab-
sence of CSL-dependent Notch signaling correlates with106 Immunity 27, 100–110, July 2007 ª2007 Elsevier Inc.decreased Gata3 expression. We have further shown
that Notch directly regulates Gata3 expression. Located
10 kb apart are two alternative noncoding first exons
of Gata3, termed exon 1a and exon 1b. Expression of
Gata3 from exon 1a- or exon 1b-derived transcripts ap-
pears to vary in different contexts. For example, Gata3
transcripts including exon 1a are expressed in developing
Th2 and neural cells, whereas transcripts including exon
1b predominate in thymocytes (Asnagli et al., 2002). The
mechanism that influences alternative exon selection
has not been previously addressed. We now show that
Notch preferentially influences expression of Gata3
Immunity 27, 100–110, July 2007 ª2007 Elsevier Inc. 107
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EMSA experiments showed association of Notch1 with
conserved CSL sites that are proximal to both exon 1a
and exon 1b, gain-of-function experiments demonstrated
a relatively large change in transcripts from exon 1a,
whereas there was no effect on exon 1b-derived tran-
scripts. This suggests that the major effect of Notch sig-
naling at the Gata3 locus is to regulate exon 1a transcrip-
tion. This preferential activation of the exon 1a transcript
may have broad implications for the way Notch activates
other genes and how Gata3 is developmentally regulated.
For example, Gata3 may be a Notch target during the ear-
liest stages of intrathymic T cell development, and these
stages are Notch dependent (Sambandam et al., 2005).
In contrast, Gata3 is likely to be expressed independently
of Notch in double-positive and single-positive thymo-
cytes, which display minimal Notch dependence (Tanigaki
et al., 2004; Tu et al., 2005; Wolfer et al., 2001).
Binding of Notch1 to the 1a and 1b sites was accompa-
nied by H4 hyperacetylation, suggesting that Notch af-
fects the chromatin structure of Gata3. We also detected
Notch1 binding at the conserved CSL-binding site in Il4
HS V, which was associated with acetylated H4 and
p300 recruitment (data not shown), consistent with a direct
role for Notch signaling in Il4 activation. In contrast, Notch
was reported to regulate IFN-g expression via direct
Notch1 regulation of Tbx21, the gene encoding the Th1
master regulator, T-bet (Minter et al., 2005). However, in
the same samples in which we found Notch bound to
Gata3 or Il4, we failed to detect endogenous Notch resid-
ing at the Tbx21 promoter (data not shown). This is consis-
tent with data obtained from two different loss-of-function
approaches that showed in vitro and in vivo defects in Th2
differentiation in the absence of CSL-dependent Notch
signaling (Amsen et al., 2004; Tu et al., 2005). Defects in
IFN-g expression or Th1 differentiation have not yet
been observed in either of the models that specifically ab-
late CSL-dependent Notch signaling. These data suggest
that the Notch signals that regulate IFN-g or Th1 differen-
tiation are likely to involve CSL-independent functions of
Notch.
GATA-3, IL-4, and STAT6 participate in an autocrine
signaling loop that acts positively on Th2 differentiation.
In addition to activating transcription of Gata3, Notch
also participates in transactivation of the Il4 gene (Amsen
et al., 2004). In the presence of DN G3, Notch was unable
to induce IL-4 expression, indicating that Gata3 is an
obligatory downstream target of Notch for IL-4 expression
and Th2 differentiation. Furthermore, our studies suggest
that the dependence of Notch on GATA-3 activity is due to
a cooperative action of Notch and GATA-3. Although ei-
ther Notch1 or GATA-3 could lead to IL-4 expression in
the absence of STAT6, the combined effect of coexpress-
ing ICN1 and GATA-3 far exceeded their additive effects.
Culturing cells in Th1 conditions suppresses the endo-
genous Gata3 gene. However, expression of the endo-
genous gene was induced by retroviral GATA-3 even in
the absence of STAT6 (Ouyang et al., 2000). Similarly,
Notch could relieve repression Gata3 repression indepen-dently of STAT6. Either ICN1 or GATA-3 induced a similar
and marked upregulation of exon 1a expression without
influencing exon 1b expression. Combined expression of
ICN1 and GATA-3 further enhanced exon 1a expression
and also enhanced (although to a lesser extent) exon 1b
expression. Sequence analysis revealed adjacent GATA
and CSL-binding sites immediately upstream of exon 1a.
The configuration of the GATA-CSL-binding sites is con-
served between humans and rodents, suggesting that
evolutionary pressure was exerted to maintain these se-
quences. In contrast, the GATA sites upstream of exon
1b are not immediately adjacent to the CSL site. Together,
our data support a model in which either Notch1 or GATA-
3 can bind sequences immediately upstream of exon 1a
leading to increased exon 1a Gata3 expression; however,
the presence of both GATA-3 and Notch1 leads to coordi-
nate binding and much greater quantities of both exon 1a
Gata3 transcripts and IL-4.
Tandem deletion of both HS VA and HS V of Il4 impairs
IL-4 expression in both CD4+ T cells and mast cells (Soly-
mar et al., 2002). The CSL-binding site resides in HS V,
whereas GATA and NFAT sites are located within HS VA.
Whether deletion of HS V alone will have a similar effect
as inactivation of Notch signals and whether Notch can
still induce IL-4 expression in the absence of HS V awaits
further studies. GATA-3 binds to HS VA, which is proximal
to HS V (Agarwal et al., 2000; Avni et al., 2002). In addition,
GATA-3 is sufficient to induce Th2-cell-specific patterns
of DNaseI hypersensitivity independently of STAT6 at
the Il4 locus (Ouyang et al., 2000). Notch may also partic-
ipate in the chromatin-remodeling function of GATA-3.
The synergistic effect of Notch and GATA-3 could reflect
cooperative recruitment of transcriptional activators and
histone acetyltransferases, such p300, leading to a tran-
scriptionally permissive chromatin state. Alternatively,
chromatin remodeling of Il4 by GATA-3 may be a prerequi-
site to a separate function of Notch.
In response to microbial stimuli, Notch ligands are upre-
gulated on dendritic cells (Amsen et al., 2004). Activation of
Notch signals during the initial events of T cell activation
may serve to induce early Gata3 expression. Alternatively,
Notch could function later in differentiation to establish sta-
ble Gata3 expression. Regardless of its temporal require-
ment, Notch seems to serve two important roles during
Th2 cell fate determination. Notch regulates expression
of the alternative exon 1a of Gata3 and induces IL-4 pro-
duction in a GATA-3-dependent and STAT6-independent
mechanism. The CSL-binding sites at the Gata3 locus re-
side within T cell-specific DNase I hypersensitivity sites
that were previously identified (Lieuw et al., 1997). Prelim-
inary data from our laboratory suggest that H4 hyperacety-
lation at these sites are Notch dependent. The effect of
Notch on chromatin structure ofGata3may also be impor-
tant for regulating memory Th2 development. The poly-
comb group protein MLL influences memory Th2 cell de-
velopment and promotes H3-K9 acetylation at the Gata3
locus (Yamashita et al., 2006). In addition, recent data
showed that Notch could regulate IL-4 in NKT cells and
in a subset of CD4+ cells that have a memory-like
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locus (Tanaka et al., 2006). We demonstrated that Notch
is required for development of the primary Th2 response
during Trichuris muris infection (Tu et al., 2005). Whether
Notch is also required for the maintenance of IL-4 or devel-
opment of memory Th2 cells in vivo awaits further studies.
A role for Notch in Th2 memory or the maintenance of IL-4
would suggest that therapeutic approaches that block
Notch signaling may benefit diseases associated with
excessive production of Th2 cytokines, such as asthma
or allergy.
EXPERIMENTAL PROCEDURES
Mice
ROSA26-DNMAML mice were previously described (Maillard et al.,
2006; Tu et al., 2005). C57Bl/6, Balb/C, and B10.D2 DO11.10 mice
were obtained from Taconic Farms (Taconic, NY). STAT6/ mice
were obtained from Jackson Labs (Bar Harbor, ME). All mice were
housed in specific pathogen-free facilities at the University of Pennsyl-
vania. Experiments were performed according to guidelines from the
National Institutes of Health with approved protocols from the Univer-
sity of Pennsylvania Animal Care and Use Committee.
TAT-Cre
Expression of TAT-cre was induced with IPTG in bacteria during log
phase of growth at 37C in the presence of chlorampenicol and carbe-
nicillin. Purification of TAT-Cre protein was carried out by the Children’s
Hospital of Pennsylvania Protein Core. 107 CD4+ T cells obtained from
DNMAMLf/fDO11.10 (B10.D2) mice were washed, resuspended in 1 ml
serum-free OPTI-MEM (Life Technologies), and incubated with 1 ml of
100 mg/ml of TAT-Cre in OPTI-MEM for 45 min at 37C. Cells were then
washed and cultured in IMDM (Life Technologies) supplemented with
10% heat-inactivated FBS, 100 U/ml penicillin, 100 mg/ml streptomy-
cin, 2 mM L-glutamine, and 50 mM 2-mercaptoethanol.
Quantitative Transcript Analysis
CD4+ T cells were isolated by positive selection with CD4 Microbeads
(Miltenyi). RNA was purified with QIAGEN RNeasy Mini Kit. cDNA was
synthesized with Superscript II kit (Invitrogen). Real-time quantitative
RT-PCR was carried out on an ABI 7900. Transcripts were amplified
with either Taqman Universal PCR Master Mix (ABI) or Sybr Green
PCR Master Mix (ABI). Primers included the following: Hprt forward
50-CTCCTCAGACCGCTTTTTGC-30, Hprt reverse 50-TAACCTGGTTC
ATCATCGCTAATC-30, Hprt probe 50-VIC-CCGTCATGCCGACCCGC
AG-TAMRA-30, Gata3 forward 50-CGAGATGGTACCGGGCACTA-30,
Gata3 reverse 50-GACAGTTCGCGCAGGATGT-30, Gata3 probe 50-
6FAM-CTGCCGACAGCCTTCGCTTGG-TAMRA-30. Exon 1a forward
50-CTGGCTGAGATGCAGTGAAG-30, Exon 1b forward 50-AGCTGTCT
GCGAACACTGAG-30, and Exon 2 reverse 50-GCTCAGAGACGGTTG
CTCTT-30.
Chromatin Immunoprecipitation
ChIP was performed with ChIP assay kits (Upstate Biotechnology).
Antibodies used were normal rabbit IgG (Upstate Biotechnology),
antiserum specific for Notch1 TAD domain (Maillard et al., 2006), a-
CSL (Chemicon), a-GATA3 (Santa Cruz), a-histone 3 (Abcam), or a-
acetylated histone 4 (Upstate Biotechnology). DNA was purified with
Qiaquick PCR purification kit (QIAGEN). DNA sequences were quanti-
fied by real-time quantitative PCR with SYBR Green (ABI) performed
on an ABI 7900HT Sequence Detection System (Applied Biosystems).
Input DNA that was not immunoprecipitated was serially diluted and
used as a standard curve to quantify levels of DNA recovered after
IP. The amount of DNA recovered from each ChIP sample was pre-
sented as a relative value to either the input of that sample or the
material recovered from a-H3 IP to correct for differences in starting108 Immunity 27, 100–110, July 2007 ª2007 Elsevier Inc.material. Primers used were as follows: exon 1a forward 50-TTCCA
CAGGGCAGTGTCATT-30, exon 1a reverse 50-CACACAAACCGCA
CATCAGA-30, exon 1b forward 50-CTCCCCTGCTCTGTGTTTCT-30,
exon 1b reverse 50-CCAGCCTGTAGGGGGTATTT-30, Il4 HS V forward
50-TTGAAGTAGCCCTCCTCACGATCA-30, and Il4 HS V reverse 50-
AGCCTCCAGACAAATTGGTGAGTG-30.
Retroviral Constructs and Transduction and T cell
Differentiation
All Notch-related cDNAs have been described (Maillard et al., 2004)
and were cloned into retroviral vectors carrying either GFP (MigR1)
or a truncated nerve growth factor receptor (NGFR) as a surrogate
marker. GATA-3-MigR1, GATA-3-NGFR, and DN G3-MigR1 were pro-
vided by Steve Reiner. Transduced DNMAML CD4+ T cells were from
a C57Bl/6 background. All other transductions were carried out in cells
from wild-type Balb/C mice. Cell culture and transductions were car-
ried out as described (Martins et al., 2005).
ELISA
Equal numbers of CD4+ T cells were plated in triplicate and restimu-
lated in wells coated with 2.5 mg/ml a-CD3. After 48 hr, standard sand-
wich ELISA protocols were used as described (Tu et al., 2005).
Flow Cytometry
Cells were restimulated, fixed, and stained as described (Tu et al.,
2005). Antibodies were peridinin chlorophyll-a protein-a-CD4, phyco-
erythrin-a-IL-4, and biotin-a-NGFR. Allophycyanin-conjugated strep-
tavidin was used as a second step for detection of NGFR. Cells were
acquired on a FACS Calibur (Becton Dickinson), and data was ana-
lyzed with FlowJo (TreeStar).
EMSA
Oligonucleotides with 50-overhangs were labeled with 32P-a-dCTP
(Perkin-Elmer) by incubation with the Klenow fragment of Escherichia
coli DNA polymerase I (New England Biolabs) for 15 min at room tem-
perature. DNA samples were purified with Microspin G-50 Columns
(Amersham Biosciences). Sequences of the oligonucleotides (Inte-
grated DNA technologies) were as follows:
exon 1a 50-TCCAACTCAGTTTCACACACCTCTGAT-30,
mutated exon 1a 50-TCCAACTCAGTTAAAAACACCTCTGAT-30,
exon 1b 50-GCGGACCGGCTGGGAATTACATGTTA-30,
mutated exon 1b 50-GCGGACCGGCTGAAAATTACATGTTA-30,
consensus CSL-binding site 50-TCCAAATTTTTTCCCACGGCG
TGT-30.
CSL and the RAM-ANK domains of Notch1 were prepared as de-
scribed (Nam et al., 2003). EMSAs were performed by incubation of
0.2 pmol of probes for 30 min at 30C in binding buffer (10% glycerol,
20 mM HEPES [pH 7.9], 60 mM KCl, 10 mM DTT, 5 mM MgCl2, 250 ng
dGdC, and 0.2 mg/ml bovine serum albumin) in the presence or
absence of 300 ng of CSL and 800 ng of RAM-ANK of ICN1.
Sequence Analysis
ECR browser is located at http://ecrbrowser.dcode.org.
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